Clinical Trial Update: Bisphosphonates for Prevention of Post-Denosumab Bone Loss [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating bisphosphonates to prevent post-denosumab bone loss; results were posted in May 2024. The study concerns osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Bisphosphonates (class)

Snippet

Sponsor: Columbia University | Conditions: IOP, Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2024-05-08